Sponsor-Investigators

Ruth O’Regan

HCRN-BRE17-141

An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy with Trastuzumab in ER-Positive, HER2-Positive Breast Cancers

Status

Cancer Types

Breast

Locations

Penn State Cancer Institute, Pennsylvania, University of Illinois Cancer Center, University of Rochester Medical Center - Wilmot Cancer Institute, University of Wisconsin Carbone Cancer Center, Wisconsin